Precise Dx Secures $20.7 Million Series B to AdvanceAI-Powered Cancer Risk Assessments
Healthcare IT Today Precise Dx, a leading innovator in oncology diagnostics leveraging Artificial Intelligence(AI) for new, morphology-driven disease analysis, today …
Read the original at Healthcare IT Today ↗
- Topics
- Healthcare
- Tags
- AI Use Case
- Tracked via
- Google Alert “AI Risks”